Subcutaneous administration of nifedipine

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Clinical Toxicology

Background:

• Hypertensive urgency requires prompt management to prevent end-organ damage.
• Nifedipine is a calcium channel blocker commonly used for hypertension.
• Physician order misinterpretation can lead to medication administration errors.

Observation:

• A 10 mg nifedipine capsule's contents were administered subcutaneously in a case of hypertensive urgency.
• The patient exhibited the intended hypotensive effect following subcutaneous nifedipine administration.
• No immediate adverse effects were observed in the patient post-administration.

Findings:

• Subcutaneous nifedipine administration appeared effective in lowering blood pressure in this specific case.
• The study reviewed existing literature on nifedipine use in hypertensive urgency.
• Current evidence does not support subcutaneous nifedipine for hypertensive urgency.

Implications:

• While seemingly effective in one instance, subcutaneous nifedipine is not a recommended treatment route.
• Further controlled studies are needed to evaluate the safety and efficacy of subcutaneous nifedipine.
• Physician order clarification protocols are crucial to prevent medication errors.